TrialBlood2019

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.

Kevin A Hay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.